Rituximab treatment in patients with active Graves' orbitopathy: effects on proinflammatory and humoral immune reactions.
about
Rituximab in the Treatment of Thyroid Eye Disease: A ReviewEfficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study.The evolving role of selenium in the treatment of graves' disease and ophthalmopathy.Efficacy of Subantimicrobial Dose Doxycycline for Moderate-to-Severe and Active Graves' Orbitopathy.Delineating the autoimmune mechanisms in Graves' diseaseThe pathophysiology of thyroid eye disease: implications for immunotherapy.Intraorbital injection of rituximab versus high dose of systemic glucocorticoids in the treatment of thyroid-associated orbitopathy.Does rituximab improve clinical outcomes of patients with thyroid-associated ophthalmopathy? A systematic review and meta-analysis.The effect of B cell depletion therapy on anti-TSH receptor antibodies and clinical outcome in glucocorticoid-refractory Graves' orbitopathy.Rapid response to and long-term effectiveness of anti-CD20 antibody in conventional therapy resistant Graves' orbitopathy: A five-year follow-up study.
P2860
Q28081573-01EDEBEA-20F4-4C5D-8FDC-D177C8575550Q35055076-505978FB-ECC7-499E-86C2-D4A60AAE45E7Q35725329-21F2EDF8-C25F-4648-8833-1D6EDEBC30F9Q35843863-0340F6BF-92E9-4DAE-A059-FB156ACC13B4Q35857020-24272395-CE6E-442D-BD99-0314F502B57DQ36439938-755E6E5D-70EB-404C-B814-0CF7D659FAECQ44766839-7B9AD647-4B58-45B3-93D4-DEE414541352Q49920960-2B3394D6-16FA-430E-8379-B7CACCA18B9AQ50795971-6167FCEB-6146-4888-8271-401E7C3C3980Q53059480-1C2A91F7-8B19-4D6D-9677-295D077C8AE1
P2860
Rituximab treatment in patients with active Graves' orbitopathy: effects on proinflammatory and humoral immune reactions.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Rituximab treatment in patient ...... and humoral immune reactions.
@en
Rituximab treatment in patient ...... and humoral immune reactions.
@nl
type
label
Rituximab treatment in patient ...... and humoral immune reactions.
@en
Rituximab treatment in patient ...... and humoral immune reactions.
@nl
prefLabel
Rituximab treatment in patient ...... and humoral immune reactions.
@en
Rituximab treatment in patient ...... and humoral immune reactions.
@nl
P2093
P2860
P50
P1476
Rituximab treatment in patient ...... y and humoral immune reactions
@en
P2093
C Guastella
G Vannucchi
P Beck-Peccoz
S Simonetta
P2860
P304
P356
10.1111/J.1365-2249.2010.04191.X
P577
2010-09-01T00:00:00Z